Modality
Fusion Protein
MOA
USP1i
Target
MDM2
Pathway
Notch
MDSFSGS
Development Pipeline
Preclinical
Mar 2017
→ Mar 2028
PreclinicalCurrent
NCT07607678
2,111 pts·FSGS
2017-03→2028-03·Active
2,111 total pts1 indication
Phase 1
Phase 2
Phase 3
NDA/BLA
Approved
CompletedCurrentUpcoming
Catalysts (1)
2028-03-202.0y awayInterim· FSGS
Trial Timeline
2017Q2Q3Q42018Q2Q3Q42019Q2Q3Q42020Q2Q3Q42021Q2Q3Q42022Q2Q3Q42023Q2Q3Q42024Q2Q3Q42025Q2Q3Q42026Q2Q3Q42027Q2Q3Q42028Q2
Preclinical
Active
Catalysts
Interim
2028-03-20 · 2.0y away
FSGS
Active|StartCompletionToday
Trials (1)
| NCT | Phase | Indication | Status | N | EP |
|---|---|---|---|---|---|
| NCT07607678 | Preclinical | FSGS | Active | 2111 | Safety |
Competitors (10)